DK488482A - Fremgangsmaade til fremstilling af 4-aroylimidazolidin-2-on - Google Patents

Fremgangsmaade til fremstilling af 4-aroylimidazolidin-2-on Download PDF

Info

Publication number
DK488482A
DK488482A DK488482A DK488482A DK488482A DK 488482 A DK488482 A DK 488482A DK 488482 A DK488482 A DK 488482A DK 488482 A DK488482 A DK 488482A DK 488482 A DK488482 A DK 488482A
Authority
DK
Denmark
Prior art keywords
alkyl
piperazino
hydrogen
lower alkyl
aroylimidazolidin
Prior art date
Application number
DK488482A
Other languages
Danish (da)
English (en)
Inventor
Richard A Schnettler
Richard C Dage
J Martin Grisar
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of DK488482A publication Critical patent/DK488482A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30Oxygen or sulfur atoms
    • C07D233/32One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30Oxygen or sulfur atoms
    • C07D233/32One oxygen atom
    • C07D233/38One oxygen atom with acyl radicals or hetero atoms directly attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Supplying Of Containers To The Packaging Station (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Fats And Perfumes (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK488482A 1981-11-04 1982-11-03 Fremgangsmaade til fremstilling af 4-aroylimidazolidin-2-on DK488482A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/317,963 US4410540A (en) 1981-11-04 1981-11-04 Cardiotonic 4-aroylimidazolidin-2-ones

Publications (1)

Publication Number Publication Date
DK488482A true DK488482A (da) 1983-05-05

Family

ID=23236021

Family Applications (1)

Application Number Title Priority Date Filing Date
DK488482A DK488482A (da) 1981-11-04 1982-11-03 Fremgangsmaade til fremstilling af 4-aroylimidazolidin-2-on

Country Status (18)

Country Link
US (1) US4410540A (ja)
EP (1) EP0079050B1 (ja)
JP (1) JPS5885865A (ja)
KR (1) KR880002708B1 (ja)
AT (1) ATE26443T1 (ja)
AU (1) AU552310B2 (ja)
CA (1) CA1175829A (ja)
DE (1) DE3275995D1 (ja)
DK (1) DK488482A (ja)
ES (1) ES8405374A1 (ja)
GB (1) GB2110669B (ja)
GR (1) GR77375B (ja)
IE (1) IE54265B1 (ja)
IL (1) IL67133A0 (ja)
NO (1) NO823648L (ja)
NZ (1) NZ202350A (ja)
PH (1) PH19029A (ja)
ZA (1) ZA827974B (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4709043A (en) * 1984-07-09 1987-11-24 Schering A.G. Process for the preparation of imidazolonecarbonylarylimidazoles
US4999365A (en) * 1987-03-20 1991-03-12 Merrell Dow Pharmaceuticals Inc. Method of reducing reperfusion injury with imidazol-2-thiones
JP2002505683A (ja) * 1997-06-18 2002-02-19 シナプティック・ファーマスーティカル・コーポレーション 複素環置換されたピペリジン類及びその使用
US6159990A (en) 1997-06-18 2000-12-12 Synaptic Pharmaceutical Corporation Oxazolidinones as α1A receptor antagonists
WO2000078754A1 (en) * 1999-06-21 2000-12-28 University Of Maryland, Baltimore Thienylhydrazon with digitalis-like properties (positive inotropic effects)
US7091238B1 (en) 1999-06-21 2006-08-15 University Of Maryland Thienylhydrazon with digitalis-like properties (positive inotropic effects)
ES2157822B1 (es) * 1999-08-17 2002-04-16 Kylolab S L Procedimiento para la sintesis de 2-imidazolidinonas poli-sustituidas.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1184709A (fr) * 1957-09-21 1959-07-24 Cfmc Nouveaux dérivés imidazoliques, utilisables comme agents de protection contre les rayons ultra-violets et leurs procédés de fabrication
US3337580A (en) * 1964-12-31 1967-08-22 Robins Co Inc A H 1-hydrocarbon-3 aryl-4-substituted ethyl-2-imidazolidinones
NZ193935A (en) * 1979-06-18 1985-05-31 Richardson Merrell Inc 4-aroyl-imidazol-2-one derivatives;pharmaceutical compositions
PH18106A (en) * 1981-02-18 1985-03-21 Merrell Dow Pharma Novel-4-aroylimidazol-2-ones

Also Published As

Publication number Publication date
ES517042A0 (es) 1984-06-16
PH19029A (en) 1985-12-06
IE822621L (en) 1983-05-04
KR880002708B1 (ko) 1988-12-26
GB2110669B (en) 1985-04-11
JPH0435465B2 (ja) 1992-06-11
AU552310B2 (en) 1986-05-29
GB2110669A (en) 1983-06-22
ES8405374A1 (es) 1984-06-16
ZA827974B (en) 1983-08-31
CA1175829A (en) 1984-10-09
ATE26443T1 (de) 1987-04-15
EP0079050B1 (en) 1987-04-08
IE54265B1 (en) 1989-08-02
KR840002362A (ko) 1984-06-25
US4410540A (en) 1983-10-18
GR77375B (ja) 1984-09-11
NO823648L (no) 1983-05-05
EP0079050A1 (en) 1983-05-18
IL67133A0 (en) 1983-03-31
NZ202350A (en) 1986-04-11
JPS5885865A (ja) 1983-05-23
AU9011182A (en) 1983-05-12
DE3275995D1 (de) 1987-05-14

Similar Documents

Publication Publication Date Title
DK488482A (da) Fremgangsmaade til fremstilling af 4-aroylimidazolidin-2-on
SE8503415D0 (sv) Novel isoindolinyl-alkyl-piperazines
DK326481A (da) Fremgangsmaade til fremstilling af i 5-stillingen substituerede 5,10-dihydro-11h-dibenzo (b,e) (1,4) diazepin-11-oner eller syreadditionssalte deraf
DK67582A (da) Fremgangsmaade til fremstilling af aroylimidazol-2-oner
ATE44648T1 (de) Antihypertensives kombinationspraeparat.
DK161787D0 (da) Asymmetriske esterderivater af 1,4-dihydropyridin-3,5-dicarboxylsyre
DK155883C (da) Analogifremgangsmaade til fremstilling af triazoloquinazolinonderivater
ATE32339T1 (de) Imidazolkarbonsaeure derivate.
SE8605458D0 (sv) 4-hydroxycoumarin derivatives
ATE28192T1 (de) 4-alkylimidazol-derivate, ihre herstellung und verwendung.
NO930844L (no) 2-(2-substituerte pyrrolidinyltio)karbapenem-derivater
DK537180A (da) Fremgangsmaade til fremstilling af 4-amino-2,6-diaryl-tetrahydrothiopyraner eller deres syreadditionssalte
SE8303131D0 (sv) Isoquinoline derivatives
DE69217148D1 (de) Isoxazole derivate als lichtschutzmittel
DK0763516T3 (da) Fremstilling og anvendelse af rene enantiomerer af 8-halogen-6-hydroxyoctansyrer, deres alkylestere og deres salte med rene enantiomerer af alfa-methylbenzylamin
DK320582A (da) Substituerede phenyl-cyclopropancarboxylsyreestere,fremgangsmaade til fremstilling deraf samt deres anvendelse som midler til bekaempelse af skadelige organismer